within Pharmacolibrary.Drugs.ATC.L;

model L01AA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.08666666666666667,
    adminDuration  = 600,
    adminMass      = 1.2,
    adminCount     = 1,
    Vd             = 0.0356,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Ifosfamide is an alkylating agent of the oxazaphosphorine group, used primarily as a chemotherapeutic agent for the treatment of various cancers including testicular cancer, sarcomas, and lymphomas. It is an FDA-approved cytotoxic drug commonly administered in combination with other chemotherapeutics.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult cancer patients (various types, both sexes), administered as intravenous infusion.</p><h4>References</h4><ol><li><p>Lewis, LD (1991). Ifosfamide pharmacokinetics. <i>Investigational new drugs</i> 9(4) 305–311. DOI:<a href=&quot;https://doi.org/10.1007/BF00183570&quot;>10.1007/BF00183570</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1804803/&quot;>https://pubmed.ncbi.nlm.nih.gov/1804803</a></p></li><li><p>Wagner, T (1994). Ifosfamide clinical pharmacokinetics. <i>Clinical pharmacokinetics</i> 26(6) 439–456. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199426060-00003&quot;>10.2165/00003088-199426060-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8070218/&quot;>https://pubmed.ncbi.nlm.nih.gov/8070218</a></p></li><li><p>Aeschlimann, C, et al., &amp; Cerny, T (1998). Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 26(9) 883–890. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9733667/&quot;>https://pubmed.ncbi.nlm.nih.gov/9733667</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01AA06;
